Inovio First to Advance Lassa Fever Candidate Vaccine Into a C...
PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire-Asianet/ -- -- Subjects dosed in First-in-Human study of INO-4500 funded by the Coalition for Epidemic Preparedness Innovations-- Planned for emergency use as a stockpiled vaccineInovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today an...
Authors: LATEST ASIANET NEWS RELEASES